Decavanadate Contribution To Vanadium Biomarkers | 60897
ISSN: 2471-8556
Oncology & Cancer Case Reports
Open Access
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The levels of vanadium in urine and blood can be used as biomarkers of exposure, but the mechanism of vanadium toxicity
is of major relevance in order to understand how biomarkes can be valuable. Our research group has performed in vivo
and in vitro studies using fish and rat models to analysed and compare the toxicity effects induce by vanadium(V) species
in the forms of vanadate (V1) and decavanadate (V10). Vanadium toxicological studies often disregarded the formation of
decameric vanadate species (V10) known to interact, in vitro, with high-affinity with many proteins such as myosin, actin and
sarcoplasmic reticulum calcium pump. Among different experimental in vivo conditions, it was analysed different: (i) mode
of administration; (ii) fish species; (iii) metal concentration (1 and 5 mM); (iv) tissues; (v) subcellular fractions ; (vi) exposure
time and particularly different metal ionic species, such as V1 and V10. It was observed that‘‘decavanadate’’ promote different
effects than other vanadate oligomers in catalase activity, glutathione content, lipid peroxidation, mitochondrial superoxide
anion production and vanadium accumulation. Moreover, in in vitro studies using fish and rat liver mitochondria, it was
observed that decavanadate impared respiration by depolarization of the mitochondrial membrane, wich altered the redox
state of complex III. Putting it all together, it is suggested that decavanadate species are much more effective than monomeric
vanadate species in inducing changes in several biomarkers. By changing mitochondrial functioning decavanadate migh
provoke ROS formation, but further studies are needed to understand V10 contribution to vanadium biomarkers.